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Classical swine fever (CSF) is a highly contagious disease of swine.
The etiological agent, classical swine fever virus (CSFV), is a small,
enveloped virus with a positive, single-stranded RNA genome and,
along with bovine viral diarrhea virus (BVDV) and border disease
virus (BDV), is classiﬁed as a member of the genus Pestivirus within
the family Flaviviridae (Fauquet et al., 2005). The approximately 12.3-
kb CSFV genome contains a single open reading frame that encodes a
3898-amino-acid polyprotein and ultimately yields 11 to 12 ﬁnal
cleavage products (NH2-Npro-C-Erns-E1-E2-p7-NS2-NS3-NS4A-
NS4B-NS5A-NS5B-COOH) through co- and posttranslational proces-
sing of the polyprotein by cellular and viral proteases (Rice, 1996).
Structural components of the CSFV virion include the Core protein and
glycoproteins Erns, E1, and E2. The function of glycoproteins, as major
virulence determinants in swine, has been studied in detail (Meyers et
al., 1999; Risatti et al., 2005a,b, 2006, 2007; Tews et al., 2009; VanGennip et al., 2004). Limited knowledge exists to explain the function
of the Core protein in Pestiviruses. CSFV Core protein, as in other
Pestiviruses, is a small, highly basic polypeptide (Meyers et al., 1989).
In BVDV, Core protein has been described as lacking signiﬁcant
secondary structure and, being a highly basic protein, capable of
binding to RNA, although with low afﬁnity and speciﬁcity (Murray et
al., 2008). In CSFV, Core, expressed as recombinant protein, has been
associated with the regulation of cellular transcriptional activation
(Liu et al., 1998). A broader knowledge of the biological properties of
hepatitis C virus (HCV) Core protein, a close relative of Pestiviruses, is
available. HCV Core has been shown to interact with itself for self-
assembling in nucleocapsid-like particles in the presence of nucleic
acids (Kunkel et al., 2001); with HCV proteins NS5A and E1 (Goh et al.,
2001; Lo et al., 1996; Masaki et al., 2008), with HCV RNA (Fan et al.,
1999; Shimoike et al., 1999; Tanaka et al., 2000), and with host
cellular proteins (Jin et al., 2000; Mamiya and Worman, 1999; Otsuka
et al., 2000; Yoshida et al., 2002; You et al., 1999). Interaction of Core
protein with cellular proteins leads to modulation of signaling
pathways, cell transformation and proliferation, regulation of cellular
and viral gene expression, apoptosis, and alteration of lipid metab-
olism that affects HCV pathogenesis (Giannini and Brechot., 2003; Lai
and Ware, 2000; Levrero, 2006; McLauchlan, 2000; Ray and Ray,
2001; Tellinghuisen and Rice, 2002). Interaction of HCV Core protein
with cell molecules impairs the host's immune response by mechan-
isms that result in suppression of IL-12 synthesis in human
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et al., 2007), and inhibition of T-lymphocyte activation and prolifer-
ation (Chen et al., 1994; Kittlesen et al., 2000; Yao et al., 2001).
Discovery of host proteins that interact with CSFV proteins may
unravel the biological properties of CSFV Core protein, including the
unknown roles in virus virulence and pathogenesis.
To increase understanding of the functions of CSFV Core protein,
we identiﬁed swine proteins that directly interact with Core of CSFV
strain Brescia by means of the yeast two-hybrid system using a swine
primary macrophage cDNA expression library. Screening revealed
that swine proteins speciﬁcally bind to Core protein. Of particular
interest, two proteins SUMO-1 and UBC9 involved in the cellular
SUMOylation pathway (Niedenthal, 2007), speciﬁcally bind to Core
protein. SUMOylation is a process that involves covalent attachment
of small ubiquitin-like modiﬁer (SUMO) proteins to speciﬁc lysine
residues in target proteins (Kerscher, 2007; Sarge and Park-Sarge.,
2009). Three SUMO isoforms, SUMO-1, SUMO-2 and SUMO-3, are
expressed in cells; in addition, a pseudogene encoding SUMO-4 has
also been described (Bohren et al., 2007). UBC9 is the SUMO-
conjugating enzyme (Niedenthal, 2007). Like ubiquitin, attachment
of SUMO to proteins involves several enzymatic steps, including
cleavage of SUMO by the speciﬁc activity of sentrin-speciﬁc protease
(SENP), to yield a mature-SUMO protein that is attached covalently to
the SUMO-activating enzyme dimer (SAE1-SAE2), an E1 protein
(Okuma et al., 1999). The SUMO protein is then transferred from
SAE1–SAE2 to SUMO-conjugating enzyme (UBC9), an E2 protein,
which attach SUMO to lysine in the target protein. Typically,
SUMOylation occurs in the consensus sequence ψKxD/E/P/G (ψ
represents a hydrophobic amino acid) (Desterro et al., 1997; Johnson
and Blobel., 1997; Rodriguez et al., 2001; Sampson et al., 2001). SUMO
E3 proteins are able to increase the efﬁciency of these reactions by
associating with UBC9 and target proteins but are not always required
for proteins to be SUMOylated (Geiss-Friedlander andMelchior, 2007;
Mukhopadhyay and Dasso, 2007). Conjugation of SUMO can induce
protein activation, affect protein stability, and cause changes in
protein intracellular locations (Kerscher, 2007). SUMOylation also
plays a role in the replication of the cell genome and regulation of
gene expression (Seeler and Dejean., 2003). Several viruses, including
human cytomegalovirus, Epstein–Barr virus, dengue virus, Moloney
murine leukemia virus, and vaccinia virus, inducemodiﬁcations to the
host SUMOylation pathway as a mechanism to evade the host
immune response (Chiu et al., 2007; Huh et al., 2008; Palacios et al.,
2005; Sadanari et al., 2005; Shirai and Mizuta., 2008; Yueh et al.,
2006).Fig. 1. Protein–protein interaction of CSFV Core with swine SUMO-1 and UBC9 proteins in
binding domain (BD) or CSFV Core fused to GAL4 binding domain (CORE–BD). These strai
activation domain (Sumo-1–AD), or UBC9 fused to GAL4 activation domain (UBC9–AD) as
2×106 yeast cells were spotted on (A) selective media for protein–protein interaction in the y
for plasmid maintenance only.Mapping of the Core–SUMO binding interface was performed by
constructing a panel of Core protein mutants where lysine (K)
residues were substituted to alanine (A) residues at the predicted
SUMO-1 binding motifs and then tested for interactions by means of
the yeast two-hybrid system. Similar mutations were introduced into
full-length cDNA clones of highly virulent CSFV strain Brescia. Rescued
mutant viruses were used to investigate whether the removal of these
sites could affect viral infectivity and virulence in swine. Interestingly,
K-to-A substitutions in Core that affect binding to SUMO-1 and UBC9
also showed an effect on induction of attenuation of CSFV in swine.Results
CSFV structural Core protein binds swine SUMO-1 and UBC9
host proteins
A yeast two-hybrid system was used to identify interactions
between swine macrophage cellular proteins and CSFV Core protein.
An N-terminal fusion of the GAL4 protein DNA binding domain (BD)
with CSFV Core protein was utilized as “bait” to screen a swine
primary macrophage cDNA library expressed as N-terminal fusion of
the GAL4 activation domain (AD). More than 1×107 independent
yeast colonies were screened from a library representing ~3×106
independent clones. Protein interactions were selected after cotrans-
fecting yeast strain AH109 with BD–Core fusion and cDNA library
constructs and selecting colonies for growth in deﬁned media lacking
amino acids leucine, tryptophan, histidine, and nucleobase adenine.
Plasmids recovered from selected yeast colonies were sequenced, and
in-frame ORFs were retested for assessing the speciﬁcity of the
observed protein interaction with CSFV Core protein. To address the
issue of false positive interactions, human lamin C protein expressed
as fusion with BD (BD–Lam) was used as “bait” in AH109 yeast
cotransfected with the swine macrophage cDNA expression library.
Nonspeciﬁc interactors were discarded (data not shown). Several
speciﬁc protein interactions with CSFV Core protein were observed.
Two of these proteins, SUMO-1 and UBC9, were selected for further
study as both proteins are involved in the cellular SUMOylation
pathway. AD–SUMO-1 and AD–UBC9 fusion proteins speciﬁcally
interacted with CSFV BD–Core fusion protein, but no protein
interactions were observed with BD protein alone (Fig. 1). Also, no
interactions were observed between AD–SUMO-1 and BD–Lam
proteins. As expected, AD–UBC9 protein interacted with BD–Lam
protein, as previously reported (Zhong et al., 2005).the yeast two-hybrid system. Yeast strain AH109 was transformed with either GAL4-
ns were then transformed with GAL4 activation domain (AD), Sumo-1 fused to GAL4
indicated above. Spots of strains, 10 μl, expressing the indicated constructs containing
east two-hybrid system, SD–Ade/His/Leu/Trp plates, and (B) nonselective SD–Leu/Trp
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Fig. 2. Schematic representation of putative SUMO binding motifs found in CSFV Core protein. Sites were predicted using SUMOplot Analysis Program (www.abgent.com/tools/
sumoplot) with CSFV strain Brescia Core protein amino acid sequence (BICv, GenBank accession number AY578687). Shown here is the CSFV polyprotein with numbers indicating
amino acid positions relative to the CSFV Brescia polypeptide.
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SUMOylation generally occurs at speciﬁc lysine (K) residues
within target proteins harboring the consensus motif ψKxD/E/P/G
(where ψ is a bulky hydrophobic residue). The SUMOplot Analysis
Program (www.abgent.com/tools/SUMOplot) predicted putative
SUMOylation sites harboring the consensus ΨKxD/E/P/G sequence
within CSFV strain Brescia Core protein (Fig. 2). Five residues within
CSFV Core, K179, K180, K220, K221, and K246 (relative to the CSFV
polyprotein) were identiﬁed as putative SUMOylation sites. Multiple
alignment of CSFV Core protein derived from isolates of diverse
geographical and temporal origins revealed a high degree of
conservancy for those K residues (Fig. 3). To assess the effects of
these residues on Core protein interactions with SUMO-1 and UBC9
proteins, K-to-A substitutions were introduced into CSFV Core gene to
yield mutant proteins CoreΔS179, CoreΔS180, CoreΔS220, Cor-
eΔS221, CoreΔS246, CoreΔS179/180, CoreΔS220/221, and Cor-
eΔS179/180/220/221 (Table 1) fused to the BD–GAL4. Protein–
protein interactions using the yeast two-hybrid system showed that
K220A substitution (CoreΔS220) alone interferes with the ability ofBICv AY578687         CSDDGASASKEKKPDRINKGKLKIAPKEHEKDSRTKPPDAT
Alfort 187 X87939     .......G.................................
LOM EU789580          .......G.................................
cF114 AF333000        .......G.................................
Alfort A19 U90951     .......G.................................
GPE- D49533           .......G.................................
Shimen AY775178       .......G.................................
JL1(06)EU497410       .......G.................................
SWH DQ127910          .......G.................................
Thiverval EU490425    .......G.................................
Eystrup NC002657      .......G.................................
ALD D49532            .......G.................................
CAP X96550            .......G.................................
Glentorf U45478       .......G.................................
HCLV AF531433         .......G...........................R.....
Strain C AY805221     .......G...........................R.....
Riems AY259122        .......G...........................R.....
CS AY578688           .......G................T................
GXWZ02 AY367767       ......GG..D.....M................K.......
virus 39 AF407339     .......G..D.....M................K..S....
Spain01 FJ265020      .......GN.D.....M................K.......
96TD AY554397         ....S.GG..D.....MS...............K.......
0406 Taiwan AY568569  ......GG..D.....M................K.......
Paderborn AY072924    ......GG.E......M................K.......
Fig. 3.Multiple alignments of CSFV Core proteins revealed the presence of highly conserved pu
comparison between CSFV isolates geographically and temporally separated. Sumoylation siteCore to interact with UBC9 (Fig. 4). However, none of the K-to-A
substitutions affected the ability of Core to interact with SUMO-1
(data not shown). Moreover, double substitutions K179A/K180A and
K220A/K221A within Core did not affect Core–SUMO-1 protein
interactions (Fig. 4). Thus, to determine if there is a cooperative
effect mediating Core–SUMO binding, truncated forms of the protein
were assayed in the yeast two-hybrid system for interactions with
SUMO-1. Both amino and carboxyl termini halves of Core retained
their SUMO-1 binding capabilities (Fig. 4). However, double substitu-
tions K179A/K180A within the Core truncated carboxyl construct and
single substitution K221A within the Core-truncated amino construct
lack the ability to interact with SUMO-1 (Fig. 4). Altogether, mapping
data indicate that Core residues K179, K180, and K221 mediate the
interaction with SUMO-1, while the interaction between Core and
UBC9 seems to be mediated by K220.
Development of CSFV SUMO-1 (CoreΔSv) mutant viruses
K-to-A substitutions of the predicted SUMOylation sites in Core
(Table 1) were introduced into the genetic background of anIVVEGVKYQVKKKGKVKGKNTQDGLYHNKNKPPESRKKLEKALLAWAVIAIMLYQPVAA
.........................................................E.
.........................................................E.
.........................................................E.
.........................................................E.
.........................................................E.
.................................................T.......E.
.................................................T.......E.
.................................................T.......E.
..........R..............................T...............E.
...................S.....................................E.
...................S.....................................E.
..................R................................V.....E.
..................R................................V.....E.
.........................................................E.
.........................................................E.
.........................................................E.
...........................................................
................................................VT.V.......
............................R...................V..V.......
.........I.........................................V.......
............N.V..................................T.V.......
.......................................K...........V.....V.
.................................................T.V.......
tative SUMOylation sites (underlined). Shown here is a Core protein amino acid sequence
s were predicted with SUMOplot Analysis Program (www.abgent.com/tools/sumoplot).
Table 1
Set of CSFV CoreΔS mutants constructed in this study.
CSFV polypeptide
position
Wild-type
sequencea
Mutant
sequence
Mutant ID
179 KEKKPDR KEAKPDR CoreΔS179v
180 KEKKPDR KEKAPDR CoreΔS180v
179/180 KEKKPDR KEAAPDR CoreΔS179/180v
220 QVQKKGK QVQAKGK CoreΔS220v
221 QVQKKGK QVQKAGK CoreΔS221v
220/221 QVQKKGK QVQAAGK CoreΔS220/221v
246 SRKKLEK SRKALEK CoreΔS246v
179, 180, 220, 221 KEKKPDR,
QVQKKGK,
KEAAPDR,
QVQAAGK,
CoreΔS179/180/
220/221v
a Bold case letters indicate the K-to-A substitutions.
KK KK K168C A267
177KEKKPDR183 243SRKKLEK249217QVKKKGK223
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Fig. 4. Schematic representation showing the observed binding patterns between wild
type and CSFV Core protein mutants with SUMO-1 and UBC9 proteins. Depicted are
putative SUMO-1 and UBC9 binding sites and K-to-A substitutions in CSFV Core
proteins. Numbers indicate amino acid position relative to CSFV strain Brescia
polypeptide.
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highly virulent CSFV strain Brescia. Rescued mutant viruses, named
CoreΔS179/180/220/221v, CoreΔS179/180v, CoreΔS220/221v, Cor-
eΔS179v, CoreΔS180v, CoreΔS220v, CoreΔS221v, and CoreΔS246v,
bear a set of single or combined K-to-A substitutions in Core at
residues K179, K180, K220, K221, and K246 (Table 1 and Fig. 2).
Nucleotide sequences of mutant virus genomes were identical to their
parental DNA plasmids, conﬁrming the presence of the introduced
substitutions and lacking undesirable mutations.
Replication of CoreΔSv mutants in vitro
In vitro growth characteristics of mutant viruses CoreΔS179/180/
220/221v, CoreΔS179/180v, CoreΔS220/221v, CoreΔS179v, Cor-
eΔS180v, CoreΔS220v, CoreΔS221v, and CoreΔS246v were evaluated
relative to parental pBIC-derived virus BICv, in a multistep growth
curve (Fig. 5). Primary swine macrophage cell cultures were infected
at a multiplicity of infection (MOI) of 0.01 TCID50 per cell. Virus was
adsorbed for 1 hour (time zero), and samples were collected at 2, 24,
48, and 72 hours postinfection (hpi). All mutant viruses exhibited
titers similar to parental BICv except CoreΔS179/180/220/221v, with
a virus yield approximately 2.5-3 log10 TCID50/ml lower than BICv
(Fig. 5). This indicates that although none of the introducedmutations
individually affected the virus titer, combined mutations signiﬁcantly
affected virus yield.
Evaluation of the role of CSFV Core SUMOylation sites in CSFV virulence
in swine
To examine the effects of deletion of Core SUMOylation sites on
CSFV virulence, CoreΔSv mutant viruses CoreΔS179/180v, Cor-
eΔS220/221v, CoreΔS220v, CoreΔS221v, CoreΔS246v and Cor-
eΔS179/180/220/221v were intranasally (IN) inoculated into naïve
swine, at doses of 105 TCID50, and monitored for clinical disease
relative to swine inoculated with virulent parental virus. BICv
exhibited a characteristic virulent phenotype (Table 2): none of the
control pigs (n=6) survived the infection, dying, or being euthanized
around 8 dpi. Interestingly, quadruple mutant CoreΔS179/180/220/
221v was completely attenuated in swine. Animals (n=4) survived
the infection and remained clinically normal throughout the entire
observation period (21 days). This virus harbors K-to-A substitutions
at residues K179, K180, K220, and K221 indentiﬁed as mediators of
Core–SUMO-1 (K179, K180, and K221) and Core-UBC9 (K220)
interactions. In contrast, all animals (n=5) inoculated with double
mutant CoreΔS179/180 (K179A/K180A) displayed severe signs of
CSF with three out of ﬁve animals succumbing to the disease, while
swine inoculated with double mutant CoreΔS220/221v (n=7)
(K220A, K221A) did not show clinical signs during the observation
period (21 days) with the exception of one animal showing a
transient rise of body temperature by 8 and 12 dpi. Animals (n=8)
inoculated with single mutant CoreΔS221v (K221A) presented avariable behavior: half of the inoculated animas (n=4) die with CSF-
associated symptoms but a signiﬁcant delay when compared with
those animals infected with parental BICv (16.2 dpi, SD=1.9, VS
8 dpi, SD=0.9, respectively). The other four animals inoculated with
CoreΔS221v survived the disease presenting either a mild CSF disease
(two animals) or were asymptomatic showing only a transitory rise in
body temperature around 4 dpi. However, animals (n=6) inoculated
with CoreΔS220v (K220A), a substitution that abolishes the Core–
UBC9 protein interaction, displayed a milder and delayed onset of the
disease relative to animals inoculated with virulent BICv, succumbing
to CSF around 17 dpi (SD=6.4). Meanwhile, pigs (n=4) inoculated
with single mutant CoreΔS246v (K246A), harboring a mutation that
does not affect Core-SUMO-1 or Core–UBC9 protein interactions,
displayed a progression of disease indistinguishable from parental
BICv infection (Table 2 and Fig. 6). Overall, these animal experiments
suggest that there appears to be a close correlation between
disrupting the protein interaction between Core–SUMO-1 and Core–
UBC9 as detected in the yeast two-hybrid system with the induction
of CSFV attenuation.
The effects of mutations introduced in Core on CSFV in vivo
spreading were analyzed in inoculated animals. Virus shedding (as
per quantiﬁcation of virus in tonsil scrapings and nasal swabs) and
viremia were quantiﬁed at times post-inoculation (Fig. 6). Virus was
not detected in samples obtained from animals inoculated with
attenuated mutant virus CoreΔS179/180/220/221v (sensitivity of
detection ≥1.8 TCID50/ml). Virus shedding was also limited in
animals inoculatedwith CoreΔS220/221v, where three of ﬁve animals
showed transient and low virus titers in blood, tonsil scrapings, and
nasal swabs samples around 14 dpi. Shedding of virus was clearly
observed in samples obtained from animals inoculated with Cor-
eΔS220v, although observed titers were lower (1.5 to 2.5 log10
depending of the time point considered) than those measured in
samples obtained from animals inoculated with parental BICv (Fig. 6).
A similar pattern of virus shedding was observed in samples coming
from animals inoculated with mutant CoreΔS179/180v (Fig. 6). Virus
titers from clinical samples from animals inoculated with CoreΔS221v
presented heterogeneous values, with the higher values being
associated with the presence of CSF-related symptoms. Therefore,
animals appearing as clinically normal do not show detectable virus
titers. Conversely, animals dying of the disease or surviving but
presenting CSF-associated symptoms present virus titers in all clinical
samples although with values substantially lower than those of the
01
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Fig. 5. In vitro growth characteristics of CoreΔS mutants and parental BICv. Primary
swine macrophage cell cultures were infected (MOI=0.01) with each of the Core
mutants or BICv and virus progeny yield titrated at different times after infection in SK6
cells. Data represent means and standard deviations from two independent experi-
ments. Sensitivity of virus detection: ≥ log10 1.8 TCID50/ml.
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of virus shedding indistinguishable from parental BICv (Fig. 6). As
with virus attenuation, shedding of CSFV as well as generalization of
infection is affected by mutations in the Core protein that have an
effect on Core protein interaction with SUMO-1 or UBC9.
Animals that survive inoculation with CoreΔS179/180/220/221v
and CoreΔS220/221v were challenged with virulent BICv by 28 dpi
were not protected, succumbing to the infection as naïve pigs (data
not shown). CSFV-speciﬁc antibodies were not detected in sera of
animals infected with either CoreΔS179/180/220/221v or Cor-
eΔS220/221v at the time of challenge.
Discussion
Here, we have observed that the structural Core protein of CSFV
speciﬁcally interacts with SUMOylation pathway proteins SUMO-1 and
UBC9. SUMO-1 binds to target proteins as part of posttranslational
modiﬁcationswhile UBC9, a proteinwith a strong sequence similarity to
ubiquitin carrier proteins (E2s), catalyzes conjugation of SUMO-1 to a
variety of target proteins (Desterro et al., 1997; Gong et al., 1997;
Johnson and Blobel., 1997). SUMO proteins attach covalently to and
detach from target proteins to modify their functions (Kerscher, 2007).
Several studies indicate that viral infections affect the cellular SUMOyla-
tion pathway (Chang et al., 2009; Chiocca, 2007). In this work, the
speciﬁc residues within CSFV Core protein mediating the interaction
with SUMO-1 and UBC9 proteins were identiﬁed. Disruption of CSFV
Core protein interaction yielded recombinant viruses with attenuatedTable 2
Swine survival and fever response following infection with CSFV CoreΔS mutants and pare
Virus No. survivors/total
no.
Mean time to death (days±
CoreΔS179/180/220/221v 4/4 No
CoreΔS179/180v 2/5a 15.3 (0.6)
CoreΔS220/221v 7/7 No
CoreΔS220v 0/6 17.5 (6.4)
CoreΔS221v 4/8c 16.2 (1.9)
CoreΔS246v 0/4 9 (0)
BICv 0/6 8 (0.9)
a The surviving animals showed severe signs of CSF at the end of the experimental perio
b Only one animal showed rise in body temperature.
c Data analysis is based in values obtained from animals showing disease.phenotypes and limited spreading within infected swine. These data
suggest a novel role for Core protein in CSFV pathogenesis and virulence
that is associated with the ability of Core protein to interact with host
proteins in the cellular SUMOylation pathway.
Modiﬁcations of SUMO-1 and UBC9 binding sites in Core yielded a
virus (CoreΔS179/180/220/221v) with substantially altered growth
characteristics in primary swine macrophage cultures (Fig. 5). These
quadruple K-to-A substitutions might affect virus growth by com-
promising other uncharacterized functions of CSFV Core, such as roles
in virus replication or virion assembly. As might be expected,
CoreΔS179/180/220/221v growth defects correlated with attenua-
tion in infected pigs. Although the attenuated CoreΔS viruses did not
show a severe growth defect in vitro, they had severe replication
impairments during infection in animals. Thus, attenuation and
spread of these viruses in vivo might be a function of altered growth
in cells, other than macrophages, that normally support growth of
wild-type CSFV. Other viral infections have been shown to affect the
cellular SUMOylation pathway. Ebola virus Zaire VP35, adenovirus
CELO Gam1, dengue virus envelope protein, human herpesvirus 6 IE2,
and human cytomegalovirus IE2 have been shown to interact with
proteins in the SUMOylation pathway either by preventing or
inducing SUMO conjugation of target proteins (Ahn et al., 2001;
Chang et al., 2009; Chiocca, 2007; Tomoiu et al., 2006), resulting on
viral interference with key cellular pathways. As observed with CSFV
protein Core, UBC9 also has been shown to interact with the capsid
(CA) protein of the Moloney murine leukemia virus (MMLV) (Yueh et
al., 2006). Binding K residues, mapped by alanine-scanning muta-
genesis, were within a consensus motif for SUMOylation, and
mutations of those residues reduced or abolished MMLV CA
SUMOylation. Different from what we have observed, MMLV CA
SUMOylation mutants displayed inhibited virus replication, being
unable to produce circular viral DNAs or integration into the nucleus.
Conversely, CSFV Core mutants were able to establish productive
infections both in vitro and in vivo. Therefore, it is possible that CSFV
Core protein interactions with the host SUMOylation pathway
contributes to curtailing viral clearance, a function that has been
removed from Core mutants.
Although the K220A substitution in Core disrupts binding to
conjugating enzyme UBC9 in the yeast two-hybrid system, we cannot
rule out the possibility that SUMOylation of Core still occurs in the
absence of binding to the SUMO-1 conjugating enzyme. That might be
reﬂected by the fact that in swine, mutant CoreΔS220v harboring the
K220A substitution that disrupts interaction with UBC9 retained its
virulence, albeit animals died later relative to animals inoculated with
wild-type virus. Similarly, mutant CoreΔS221v was only partially
attenuated in swine. Individual K179A or K180A substitutions in BICv
do not affect virus virulence (data not shown); only the double mutant
CoreΔS179/180v was partially attenuated in swine. Interestingly,
simultaneous mutation of K220A and K221A in CΔS220/221v, losing
the binding to both SUMO-1 and UBC9, leads to a strong attenuation ofntal BICv.
SD) Fever
No. days to onset
(days±SD)
Duration no. days
(days±SD)
Max daily temperature
(± SD)
No No 103.3 (0.4)
4.4 (1.5) 11.8 (3.4) 106.1 (1)
8b 4 103.1 (0.4)
4.2 (0.8) 11 (2.9) 106.4 (0.4)
5.8 (2.7) 8.8 (4) 105.6 (0.4)
4.6 (0.7) 4.7 (0.8) 105.8 (0.4)
3.1 (0.7) 5.6 (1.2) 106.4 (0.9)
d (21 days).
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Fig. 6. Virus titers in clinical samples (blood, tonsil scrapings, and nasal swabs) from
pigs infected with CoreΔS mutants and parental BICv. Each point represents the mean
log10 TCID50/ml and standard deviations from at least two animals. Sensitivity of virus
detection: ≥ log10 1.8 TCID50/ml.
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binding requires all four Lys residues (K179. K180, K220, and K221),
since complete attenuation of wild-type virus was observed only when
all four K-to-A substitutions were introduced into Core protein.
In general, SUMO-targeted proteins exhibit SUMOylation-dependent
subcellular localization (Sarge and Park-Sarge, 2009). However, substi-
tution of SUMOylation site lysines in ataxin-1 did not affect ataxin-1, acellular protein, nuclear localization or its ability to form inclusions.
Analysis of CSFV Core protein localization in swine cells using GFP–Core
fusion proteins showed that substitutions of all putative SUMOylation
sites donot affect cellular localizationwith core appearing in thenucleus,
and in small structures within the cell (data not shown).
In summary, we identiﬁed the ﬁrst swine host protein-binding
partners for the CSFV Core protein: SUMO-1 and UBC9. Both of these
proteins are involved in the SUMOylation pathway, and the putative
binding/SUMOylation residues were mapped to two distinct regions
in the Core protein. Furthermore, it is shown that disruption of
speciﬁc residues within these distinct regions of Core protein
completely abrogate virus virulence, demonstrating that acquisition
of attenuation correlates with loss of binding to components of the
SUMOylation pathway, SUMO-1 and UBC9. Although the role of
SUMOylation within CSFV Core function is not clear, data indicates
that the mechanism may support virus proliferation. It is of
paramount importance to gain insights into host–viral protein
interactions to understand the mechanisms of viral virulence and
immune system evasion. Understanding the pathways and the
protein players involved is necessary for developing and understand-
ing better countermeasures to control virus infection in swine.
Materials and methods
Viruses and cells
Swine kidney cells (SK6) (Terpstra et al., 1990), free of BVDV, were
cultured in Dulbecco's minimal essential media (DMEM) (Gibco,
Grand Island, NY) with 10% fetal calf serum (FCS) (Atlas Biologicals,
Fort Collins, CO). CSFV strain Brescia was propagated in SK6 cells and
used for the construction of an infectious cDNA clone (IC) (Risatti et
al., 2005a). Growth kinetics was assessed on primary swine
macrophage cell cultures prepared as described (Zsak et al., 1996).
Titration of CSFV from clinical samples was performed using SK6 cells
in 96-well plates (Costar, Cambridge, MA). Viral infectivity was
detected, after 4 days in culture, by an immunoperoxidase assay using
the CSFV monoclonal antibody WH303 (Edwards et al., 1991) and the
Vectastain ABC kit (Vector Laboratories, Burlingame, CA). Titers were
calculated using themethod of Reed andMuench, 1938 and expressed
as TCID50/ml. As performed, test sensitivity was ≥1.8 TCID50/ml.
Construction of CSFV CoreΔS (CΔS) mutants
A full-length IC of the virulent CSFV Brescia strain (pBIC) (Risatti et
al., 2005a) was used as a template in which putative SUMO binding
sites in the Core protein were mutated. SUMO binding sites were
predicted using the SUMOplot Analysis Program (www.abgent.com/
tools/SUMOplot) with the consensus sequence ΨKxD/E/P/G (where
Ψ is a bulky hydrophobic residue) within CSFV strain Brescia Core
protein [GenBank accession number AY578687, (Risatti et al., 2005a)]
(Figs. 2 and 3). Lysine (K)-to-alanine (A) amino acid substitutions
were introduced by site-directed mutagenesis using the QuickChange
XL Site-Directed Mutagenesis kit (Stratagene, Cedar Creek, TX;
Table 1) performed per manufacturer's instructions and using the
following primers (only forward primer sequences are shown):
CoreΔS179: 5′-ggtgcaagtgcaagtaaagaggcgaaaccagataggatcaacaa-3′; Cor
eΔS180: 5′-gcaagtgcaagtaaagaga aggcaccagataggatcaacaaggg-3′; Cor
eΔS220: 5′-ggaaggagtaaaataccaggtcaaagcgaaaggtaaagttaagggaaag aat-
3′; CoreΔS221: 5′-aggagtaaaataccaggtcaaaaaggcaggtaaagttaagggaaagaa
tacc-3′; CoreΔS246: 5′-aataa accaccagaatctaggaaggcattagaaaaagccc
tattggcatg-3′; CoreΔS179/180: 5′-ttgtagtggaaggagtaaaataccaggtc a
aagcggcaggtaaagttaagggaaagaatacc-3′ CoreΔS220/221: 5′-gatggtg
caagtgcaagtaaagaggcggcaccagataggat caacaagggtaa-3′; and CoreΔS179/
180/220/221: 5′-ttgtagtggaaggagtaaaataccaggtcaaagcggcaggtaaa
gttaagggaaagaatacc-3′ and 5′-gatggtgcaagtgcaagtaaagaggcggcaccaga
taggatcaacaagggtaa-3′ .
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Full-length genomic clones were linearized with SrfI and in vitro
transcribed using the T7 MEGAscript system (Ambion, Austin, TX).
RNA was precipitated with LiCl and transfected into SK6 cells by
electroporation at 500 V, 720 Ω, 100 Wwith a BTX 630 electroporator
(BTX, San Diego, CA). Cells were seeded in 12-well plates and
incubated for 4 days at 37 °C and 5% CO2. Virus was detected by
immunoperoxidase staining as described above, and stocks of rescued
viruses were stored at −70 °C.
DNA sequencing and analysis
Full-length clones and in vitro-rescued viruses were completely
sequenced with CSFV-speciﬁc primers by the dideoxynucleotide
chain-termination method (Sanger et al., 1977). Viruses recovered
from infected animals were sequenced in the mutated region.
Sequencing reactions were prepared with the Dye Terminator Cycle
Sequencing Kit (Applied Biosystems, Foster City, CA). Reaction
products were sequenced on an ABI PRISM 3730xl automated DNA
sequencer (Applied Biosystems, Foster City, CA). Sequence data were
assembled with the Phrap software program (http://www.phrap.
org), with conﬁrmatory assemblies performed using CAP3 (Huang
andMadan., 1999). The ﬁnal DNA consensus sequence represented an
average ﬁve-fold redundancy at each base position. Sequence
comparisons were conducted using BioEdit software (http://www.
mbio.ncsu.edu/BioEdit/bioedit.html).
Development of the cDNA library
A porcine macrophage cDNA expression library was constructed
(Clontech, Mountain View, CA) using monocytes/macrophages
obtained from healthy noninfected 40-lb swine. Macrophage cultures
were prepared from deﬁbrinated swine blood. Cells were cultured in
plastic Primaria tissue culture ﬂasks (BD Falcon, Franklin Lakes, NJ) in
Roswell Park Memorial Institute-1640 medium (RPMI 1640; Invitro-
gen, Carlsbad, CA) containing 30% vol./vol. L929 cell supernatant, 20%
fetal bovine serum (Invitrogen), and antibiotics–antimycotics (Invi-
trogen), for 48 hours (37 °C in 5% CO2). Adherent cells were detached
from the plastic by using 10 mM EDTA in phosphate-buffered saline
and then reseeded into Primaria 6-well dishes at a density of 5×106
cells per well and incubated for an additional 24 hours at 37 °C in 5%
CO2. Cells were detached using 10 mM EDTA in phosphate-buffered
saline, spun at 500×g for 10 minutes, with subsequent total RNA
extraction using an RNeasy Mini kit (Qiagen, Valencia, CA). Contam-
inant genomic DNA was removed by DNase treatment using TURBO
DNA-free (Ambion, Austin, TX). After DNase treatment, genomic DNA
contamination of RNA stocks was assessed by real-time PCR
ampliﬁcation targeting the porcine β-actin gene. RNA quality was
assessed by using RNA Nano chip on an Agilent Bioanalyzer 2100
(Agilent, Santa Clara, CA). Cellular proteins were expressed as GAL4
activation domain (AD) fusion proteins while CSFV proteins were
expressed as GAL4-binding domain (BD) fusion proteins.
Library screening
The GAL4-based yeast two-hybrid system provides a transcriptional
assay for detection of protein–protein interactions (Chien et al., 1991;
Fields and Song, 1989). The “bait” protein, CSFV strain Brescia Core
protein, was expressed with an N-terminus fusion to the GAL4 binding
domain (BD). Full-length Core protein (amino acid residues 168–268 of
the CSFV polyprotein)was used for screening and for full-lengthmutant
protein construction. The Core fragments used for mapping were made
using amino acids 168–212 for the amino half and amino acids 211–268
for the carboxyl half. As “prey,” the previously described swine
macrophage cDNA library containing proteins were fused to the GAL4activation domain (AD) was used. Histidine and adenine reporter genes
were used for growth selection in addition to two-color selection genes,
X-gal (blue+/white−) and X-α-gal (blue+/white−). The swine macro-
phage library used here contains 3×106 independent cDNA clones. To
screen, yeast strain AH109 (Clontech) carrying Core protein was
transformed with library plasmid DNA with subsequent selection on
plates lacking tryptophan, leucine, histidine, and adenine. Tryptophan
and leucine are used for plasmid selection, while histidine and adenine
are used for identiﬁcation of positive interacting library fusions. Once
identiﬁed, thepositive libraryplasmidswere recovered inEscherichia coli
and sequenced to identify the cellular interacting protein. Sequence
analysis also determined if the library proteins (cellular) were in-frame
with the activation domain. To eliminate false positive interactions all
library–activation domain fusion proteins were retransformed into
strains carrying the viral protein-bindingdomain fusion proteins, aswell
as into strains carrying a Lam-binding domain fusion, with vectors that
only contain the binding domain as negative controls. Lam is human
Lamin C, commonly used as a negative control in the yeast two-hybrid
system, as Lamin C does not form complexes or interact withmost other
proteins; however, some studies have shown Lamin C to interact with
UBC9, thus binding domain-only vector was used for this purpose. The
SUMO-1 recovered from the library contained amino acids (29–101) of
porcine SUMO-1 (NCBI Reference Sequence: NP_001106146.1) amino
terminal fused to the GAL4 activation domain. The UBC9 protein
recovered was similar to Homo sapiens UBC9 (93% identity) and
contained amino acids 2–172 of H. sapiens UBC9 (BAD92225) amino
terminal fused to the GAL4 activation domain.Animal infections
Each of the Core mutants or CoreΔSv was initially screened for its
virulence phenotype in swine relative to the virulent strain Brescia.
Swine used in all animal studies were 10 to 12 weeks old, 40-lb
commercial breed pigs inoculated intranasally with 105 TCID50 of either
mutant or wild-type parental virus (BICv). For screening, pigs were
randomly allocated into groups of at least two animals each, and pigs in
each group were inoculated with one of the CoreΔSv (Table 1) or BICv.
Clinical signs (anorexia, depression, purple skin discoloration, staggering
gait, diarrhea, and cough) and changes in body temperature were
recorded daily throughout the 21-day experiment. Total and differential
white blood cell and platelet counts were obtained using a Beckman
Coulter ACT (Beckman, Coulter, CA). Blood, serum, nasal swabs and
tonsil scrapings were collected at times after challenge. Samples were
processed for virus detection as described before (Risatti et al., 2005a).
For protection studies, pigs were inoculated with 105 TCID50 of the
corresponding CoreΔSv. At 28 days postinoculation (DPI) animals
were intranasally challenged with 105 TCID50 of BICv. Clinical signs
and body temperature were recorded daily throughout the experi-
ment as described above. CSFV antibodies were detected in sera using
a commercially available ELISA (IDEXXHerdCheck CSFV Antibody Test
Kit, Westbrook, ME).Acknowledgments
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